The District Court has Criticized the Significant Rise in Class Actions Lawsuits Filed Against Pharmaceutical Companies
Categories: Dispute Resolution
The District Court has criticized the significant rise in class actions lawsuits filed against pharmaceutical companies In its decision in the recent Teva case, the Court stated that it will not accept applications to approve class action lawsuits that are lacking relevant medical reports, and will not enable plaintiffs to abuse their rights to appeal Learn more in the client update shared by our attorneys Hagai Doron and Dovev Apel in relation to this case, in which they represented Teva Pharmaceuticals Industries Ltd.
